Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle.

Back

ESC Professional Premium Access

Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle.

Session: Mitochondria and other regulators of cardiac disease

Topic: Gene Therapy, Cell Therapy

Speaker: Doctor D. Santiago Castillo (Madrid, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Demetrio Julian Santiago Castillo

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

0 follower

6 more presentations in this session

Impact of microtubule detyrosination on subcellular distribution of Nav1.5 in mdx cardiomyocytes

Speaker: Doctor S. Casini (Amsterdam, NL)

Mitochondrial and contractile dysfunction in a swine model of early chronic kidney disease

Speaker: Doctor P. Sen (Munich, DE)

Mitochondrial heteroplasmy as a marker for premature coronary artery disease: analysis of the poly-C tract of the control region sequence

Speaker: Mr F. Gonzalez Urbistondo (Oviedo, ES)

Upregulation of mitochondrial fusion as potential cardioprotective strategies against trastuzumab-induced cardiotoxicity in rats

Speaker: Doctor C. Maneechote (Chiang Mai, TH)

Validation of mitochondrial function measurements in permeabilized myocardial tissue from porcine left ventricular specimens with ischemia/reperfusion

Speaker: Ms C. Eickelmann (Essen, DE)

Access the full session

Mitochondria and other regulators of cardiac disease

Speakers: Doctor D. Santiago Castillo, Doctor S. Casini, Doctor P. Sen, Mr F. Gonzalez Urbistondo, Doctor C. Maneechote...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources